30.8 C
Thursday, June 13, 2024

A New Year of Community and Connection

Happy new year—welcome to the first issue of your member magazine in 2024.  This month, ASCO celebrates the 20th anniversary of the Genitourinary Cancers Symposium with reflections from leaders, founders, and attendees on two decades of the meeting. Their words, and the event itself, are a testament to the power of community—of what we can...

Celebrating the 18th Annual Best of ASCO in Beirut

It was such a great pleasure and satisfaction to organize and hold the 18th Annual Best of ASCO (BOA) Lebanon Meeting on July 7-8, 2023, at the American University of Beirut Medical Center (AUBMC) in a hybrid format from the Daniel ACC Building Ground Floor Conference Rooms. Speakers and attendees in Lebanon were present...

Urine Test Predicts Future Bladder Cancer 12 Years Before Symptoms

A 10-gene assay predicted future cases of urothelial cancer, the most common form of bladder cancer, with a high degree of sensitivity and specificity. Medscape Medical News

Gemcitabine-Docetaxel Effective Alternative to BCG in NMIBC

The chemotherapy duo performed better than expected as a stand-in for bacillus Calmette-Guérin (BCG), which is the gold standard for non–muscle-invasive bladder cancer but is currently in short supply. Medscape Medical News

Pembrolizumab Activity in BCG-Refractory Papillary Bladder Cancer

Pembrolizumab monotherapy showed promising antitumor activity for patients with high-risk non–muscle invasive bladder cancer that did not respond to standard treatment with BCG. Medscape Medical News

Judge Weighs Key Evidence Ahead of First Zantac Cancer Trial

Lawyers for a man who alleges he developed bladder cancer after taking heartburn drug Zantac urged a California judge on Thursday to allow expert testimony at an upcoming trial. Reuters Health Information

Atezolizumab Bladder Cancer Indication Withdrawn in US

The manufacturer has voluntarily withdrawn the US indication that covered its use in certain patients with bladder and urinary tract cancers. Medscape Medical News

Intra-Arterial Chemo Improves Outcomes in Bladder Cancer

Adding intra-arterial chemo to standard BCG therapy may reduce recurrence risk for patients with non–muscle-invasive bladder cancer. The study was published as a preprint and has not yet been peer reviewed. First Look

Firefighting a Carcinogenic Occupation, Warn Experts

Firefighters have occupational exposure that meets five of the 10 criteria for being carcinogenic and is directly related to increased rates of mesothelioma and bladder cancer, say international experts. Medscape Medical News

BCG Vaccine Benefit in Non–Muscle Invasive Bladder Cancer?

Among patients with very high-risk but not high-risk disease, bacillus Calmette-Guérin more effectively delayed time to progression compared with transurethral resection of the bladder. Medscape Medical News

Time Management Tips


overcast clouds
30.8 ° C
32.8 °
27.8 °
37 %
92 %
38 °
34 °
30 °
32 °
29 °

Must Read